Video

A Healthy Lifestyle Will Help Patients Get Through Myeloma Treatment

Author(s):

It is essential for patients to live a healthy lifestyle while undergoing treatment for multiple myeloma, an expert said.

When undergoing treatment for multiple myeloma, it is essential that patients take up healthy habits to mitigate or control other health conditions and be able to tolerate potential side effects of the cancer treatment, explained Dr. Krina K. Patel.

READ MORE: How a Nutritious Diet May Help During Myeloma Treatment

In a recent interview at the 2023 European Hematology Association Congress, Patel, who is an associate professor in the Department of Lymphoma/Myeloma, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas, emphasized the importance of healthy lifestyle for individuals undergoing myeloma treatment. And, with many clinical trials having eligibility criteria based onhow healthy a patient is overall and how independently they can perform their daily tasks, this is particularly important for patients hoping to participate in the research of new drugs and therapies, according to Patel.

Transcription

I tell my patients that … even though we're talking about myeloma all the time, I want your heart and your brain and your kidneys to be really good, too. So it's really important to do everything you can to stay as healthy as possible.

You know, we want your quality of life to be good, but to do that, you still have to be healthy. So really, it's about your performance status and other comorbidities … Any treatment I want to give you, I want to make sure I'm not going to make things worse for you, right? So especially those patients who are in early-line induction therapy, and now just went through either transplant or on maintenance (therapy, which aims to prevent disease from coming back), that's the time to really start working on getting in shape and changing lifestyle habits so that we can actually get you through these other therapies. They are overall safe. But you know, nothing has zero toxicity.

So, I will say the majority of my patients are eligible for these trials. But again, it's really making sure it's the right thing at the right time for you, and that we've optimized the rest of your body and mind to get you through this so that you can enjoy that quality of life after.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.